The average one-year price target for Terumo (OTCPK:TRUMF) has been revised to $23.38 / share. This is an increase of 14.97% from the prior estimate of $20.33 dated November 9, 2025. The price target ...

The average one-year price target for Terumo (OTCPK:TRUMF) has been revised to $19.81 / share. This is a decrease of 15.25% from the prior estimate of $23.38 dated November 16, 2025. The price target ...

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional ...

Terumo Corp (TRUMF) achieved record high sales revenues surpassing JPY1 trillion for the first time, with a 12% growth over the previous year. Operating profit reached a record high for the fourth ...

Terumo Corp (TRUMF) achieved record high quarterly revenue of 260 billion for Q1, with a 6% growth excluding foreign exchange impacts. Operating profit grew significantly faster than revenue, reaching ...

Replay the call for the latest insights. Loading chart for TRUMF ...

At close: 12 November at 16:00:00 GMT-5 ...

Terumo Corp. Terumo Corp. engages in the manufacture and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and ...

As of May 5 at 4:00:00 p.m. EDT. Market Open.

Terumo Corp. Annual cash flow by MarketWatch. View TRUMF net cash flow, operating cash flow, operating expenses and cash dividends.